Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald F Watts

Showing results (411-420 of 706) with videos related to

Pageof 71
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 19, 2015
The potential role of an expert computer system to augment the opportunistic detection of individuals with familial hypercholesterolaemia from a community laboratoryDamon A Bell, Glenn Edwards, Amanda J Hooper, et al.
Clinical Chemistry|January 15, 2005
Adiponectin and other adipocytokines as predictors of markers of triglyceride-rich lipoprotein metabolismDick C Chan, Gerald F Watts, Theodore W K Ng, et al.
European Heart Journal|March 23, 2018
Controlled study of the effect of proprotein convertase subtilisin-kexin type 9 inhibition with evolocumab on lipoprotein(a) particle kineticsGerald F Watts, Dick C Chan, Ransi Somaratne, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 13, 2010
Nonalcoholic fatty liver disease as the transducer of hepatic oversecretion of very-low-density lipoprotein-apolipoprotein B-100 in obesityDick C Chan, Gerald F Watts, SengKhee Gan, et al.
Frontiers in Endocrinology|March 6, 2023
Is type 2 diabetes associated dementia a microvascular early-Alzheimer's phenotype induced by aberrations in the peripheral metabolism of lipoprotein-amyloid?Ryusuke Takechi, Arazu Sharif, Emily Brook, et al.
Journal of Clinical Lipidology|December 7, 2016
Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictionsKatrina L Ellis, Jing Pang, Dick C Chan, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2018
A Comparative Analysis of Phenotypic Predictors of Mutations in Familial HypercholesterolemiaDick C Chan, Jing Pang, Amanda J Hooper, et al.
Atherosclerosis|June 12, 2020
Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: Many happy returns on investment?Zanfina Ademi, Richard Norman, Jing Pang, et al.
Translational Neurodegeneration|January 21, 2024
The therapeutic potential of probucol and probucol analogues in neurodegenerative diseasesArazu Sharif, John Mamo, Virginie Lam, et al.
The American Journal of Cardiology|October 30, 2016
Effect of Alirocumab on Lipoprotein(a) Over ≥1.5 Years (from the Phase 3 ODYSSEY Program)Daniel Gaudet, Gerald F Watts, Jennifer G Robinson, et al.
Pageof 71

Showing results (411-420 of 706) with videos related to

Sort By:
Pageof 71
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 19, 2015
The potential role of an expert computer system to augment the opportunistic detection of individuals with familial hypercholesterolaemia from a community laboratoryDamon A Bell, Glenn Edwards, Amanda J Hooper, et al.
Clinical Chemistry|January 15, 2005
Adiponectin and other adipocytokines as predictors of markers of triglyceride-rich lipoprotein metabolismDick C Chan, Gerald F Watts, Theodore W K Ng, et al.
European Heart Journal|March 23, 2018
Controlled study of the effect of proprotein convertase subtilisin-kexin type 9 inhibition with evolocumab on lipoprotein(a) particle kineticsGerald F Watts, Dick C Chan, Ransi Somaratne, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 13, 2010
Nonalcoholic fatty liver disease as the transducer of hepatic oversecretion of very-low-density lipoprotein-apolipoprotein B-100 in obesityDick C Chan, Gerald F Watts, SengKhee Gan, et al.
Frontiers in Endocrinology|March 6, 2023
Is type 2 diabetes associated dementia a microvascular early-Alzheimer's phenotype induced by aberrations in the peripheral metabolism of lipoprotein-amyloid?Ryusuke Takechi, Arazu Sharif, Emily Brook, et al.
Journal of Clinical Lipidology|December 7, 2016
Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictionsKatrina L Ellis, Jing Pang, Dick C Chan, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2018
A Comparative Analysis of Phenotypic Predictors of Mutations in Familial HypercholesterolemiaDick C Chan, Jing Pang, Amanda J Hooper, et al.
Atherosclerosis|June 12, 2020
Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: Many happy returns on investment?Zanfina Ademi, Richard Norman, Jing Pang, et al.
Translational Neurodegeneration|January 21, 2024
The therapeutic potential of probucol and probucol analogues in neurodegenerative diseasesArazu Sharif, John Mamo, Virginie Lam, et al.
The American Journal of Cardiology|October 30, 2016
Effect of Alirocumab on Lipoprotein(a) Over ≥1.5 Years (from the Phase 3 ODYSSEY Program)Daniel Gaudet, Gerald F Watts, Jennifer G Robinson, et al.
Pageof 71